3 completed. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow Dexmethylphenidate Hydrochloride: new trials by email Literature Review of Dexmethylphenidate Hydrochloride trials Research Report on Dexmethylphenidate Hydrochloride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CTx-1301 Comparative Bioavailability Study Dexmethylphenidate 5 Mg Oral Capsule, Extended Release, Dexmethylphenidate 6.25 mg Tablet, Dexmethylphenidate 40 Mg Oral Capsule, Extended Release - ADHD | Phase 1 / Phase 2 | Completed | Cingulate Therapeutics | 45 | 2019-12-06 | 2021-04-08 |
| Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits ADHD Medication, Omega-3 Fatty Acids - Attention Deficit Hyperactivity Disorder (ADHD), Deficient Emotional Self-Regulation (DESR) | Phase 2 | Completed | Massachusetts General Hospital | 2 | 2012-02-01 | 2018-10-23 |
| Study of Dopamine Transporter Receptor Occupancy With Long-acting Dex-methylphenidate dex-methylphenidate - Drug Binding to DAT Receptors | Phase 1 / Phase 2 | Completed | Massachusetts General Hospital | 23 | 2006-12-01 | 2013-10-22 |
Attention Deficit Disorder with Hyperactivity (2)
Massachusetts General Hospital (2) · Cingulate Therapeutics (1)
United States (3)
Craig Surman, MD (1) · Matt Brams, MD (1) · Thomas Spencer, MD (1)